Axelys
Montreal, QC
Investment Thesis
Axelys is a Quebec-focused technology-transfer investor created from the merger of Univalor, Sovar, and Aligo, specializing in early-stage Life Sciences and Deep Tech spinouts from public research institutions. The fund actively holds equity in science-based ventures originating from leading Quebec research centers including CHUM and CRCHUM, prioritizing pre-seed and seed stage companies with strong institutional research origins.
Focus Areas
Investment Stage
Pre-SeedSeed
Sectors
Investment Signals
GeographyCanada-focused
ProvincesQC
Revenue Stagepre-revenue ok
Business Modelsdeep-tech, IP-licensing
AUM & Sources
N/A
Assets under management (estimated)
Sources
No public sources found.
Raising from Canadian VCs?Get AI-matched to your top investors in seconds.
Find My Investors →Similar Funds
See incorrect information?
Help us keep this directory accurate and up to date.